DEINOVE IS INCLUDED IN THE 40 HOTTEST SMALL COMPANIES IN THE ADVANCED BIOECONOMY FOR 2015-16
DEINOVE is the leading French company in this ranking and the second in Europe
Montpellier, 5 November 2015 - DEINOVE (Alternext Paris: ALDEI), a biotech company developing innovative processes for producing biofuels and bio-based chemicals by using Deinococcus bacteria as host strains, announces today that it took the 19th spot in the "40 Hottest Small[1] Companies in the Advanced Bioeconomy" that will make great contributions to the global bio-economy. The ranking was announced during the ABLC NEXT 2015 conference held in San Francisco from 2 to 5 November.
The TOP 40 recognizes emerging companies, mostly American, for their innovation and achievements in biofuels, biobased chemicals and materials. It is based 50 percent on votes from an invited panel of renowned international guests, and 50 percent on votes from readers of the Biofuels Digest (world's most widely-read advanced bioeconomy daily).
"Being the leading French company in this ranking and the second one in Europe is an honor. This recognition is even more significant because it stems from the choice of experts and an informed and international audience in our sector. We have great ambitions for DEINOVE and intend to demonstrate that this ranking reflects a reality that will be implemented in the coming years," says Emmanuel Petiot, CEO of DEINOVE.
About DEINOVE
DEINOVE (Alternext Paris: ALDEI) is ushering in a new era of green chemistry by designing and developing new standards of production based on bacteria of untapped potential: the Deinococci. Taking advantage of the bacteria's unique genetic properties and unusual robustness, DEINOVE optimizes natural fermentation and metabolic capabilities of these bacterial "micro-factories" to produce high value-added products from non-food biomass. The Company's primary markets are 2nd-generation biofuels (DEINOL) and bio-based chemicals (DEINOCHEM). On these markets, the Company offers its technology to industrial partners globally.
Listed on NYSE Alternext since April 2010, DEINOVE was founded by Dr. Philippe Pouletty, General Partner of TRUFFLE CAPITAL, and Pr. Miroslav Radman, of the Faculty of Medicine of Paris Descartes University. The company employs almost 50 people in its offices and laboratories located in Montpellier, France.
More information at www.deinove.com
Contacts
| DEINOVE Emmanuel Petiot CEO Tel.: +33 (0)4 48 19 01 28 emmanuel.petiot@deinove.com | Coralie Martin Communication, Marketing and IR Manager Tel.: +33 (0)4 48 19 01 60 coralie.martin@deinove.com |
| ALIZE RP, Press Relations Caroline Carmagnol / Wendy Rigal Tel.: +33 (0)1 44 54 36 66 deinove@alizerp.com |  |
[1] i.e. any company with less than 100 full-time employees and $20 million or less in annual revenues
